Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies
AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus,...
Uloženo v:
| Vydáno v: | BMJ (Online) Ročník 375; s. n2213 |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
British Medical Journal Publishing Group
13.10.2021
BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Témata: | |
| ISSN: | 1756-1833, 0959-8138, 1756-1833 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Study selectionProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Data synthesisSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.Results41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).ConclusionsThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.Systematic review registrationPROSPERO CRD42021229487. |
|---|---|
| AbstractList | AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Study selectionProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Data synthesisSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.Results41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).ConclusionsThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.Systematic review registrationPROSPERO CRD42021229487. To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.OBJECTIVETo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.Systematic review and meta-analysis of prospective cohort studies.DESIGNSystematic review and meta-analysis of prospective cohort studies.PubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.DATA SOURCESPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Prospective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.STUDY SELECTIONProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Summary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.DATA SYNTHESISSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).RESULTS41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).The findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.CONCLUSIONSThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.PROSPERO CRD42021229487.SYSTEMATIC REVIEW REGISTRATIONPROSPERO CRD42021229487. ObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer.DesignSystematic review and meta-analysis of prospective cohort studies.Data sourcesPubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021.Study selectionProspective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer.Data synthesisSummary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality.Results41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I2=77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I2=48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I2=5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I2=3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I2=76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I2=30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I2=8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I2=37.1%, n=14).ConclusionsThe findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only.Systematic review registrationPROSPERO CRD42021229487. To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease (CVD), and cancer. Systematic review and meta-analysis of prospective cohort studies. PubMed, Scopus, ISI Web of Science, and Google Scholar to 30 April 2021. Prospective cohort studies that reported the risk estimates for death from all causes, CVD, and cancer. Summary relative risks and 95% confidence intervals were calculated for the highest versus lowest categories of ALA intake using random effects and fixed effects models. Linear and non-linear dose-response analyses were conducted to assess the dose-response associations between ALA intake and mortality. 41 articles from prospective cohort studies were included in this systematic review and meta-analysis, totalling 1 197 564 participants. During follow-up ranging from two to 32 years, 198 113 deaths from all causes, 62 773 from CVD, and 65 954 from cancer were recorded. High intake of ALA compared with low intake was significantly associated with a lower risk of deaths from all causes (pooled relative risk 0.90, 95% confidence interval 0.83 to 0.97, I =77.8%, 15 studies), CVD (0.92, 0.86 to 0.99, I =48.2%, n=16), and coronary heart disease (CHD) (0.89, 0.81 to 0.97, I =5.6%, n=9), and a slightly higher risk of cancer mortality (1.06, 1.02 to 1.11, I =3.8%, n=10). In the dose-response analysis, a 1 g/day increase in ALA intake (equivalent to one tablespoon of canola oil or 0.5 ounces of walnut) was associated with a 5% lower risk of all cause (0.95, 0.91 to 0.99, I =76.2%, n=12) and CVD mortality (0.95, 0.91 to 0.98, I =30.7%, n=14). The pooled relative risks for the highest compared with lowest tissue levels of ALA indicated a significant inverse association with all cause mortality (0.95, 0.90 to 0.99, I =8.2%, n=26). Also, based on the dose-response analysis, each 1 standard deviation increment in blood concentrations of ALA was associated with a lower risk of CHD mortality (0.92, 0.86 to 0.98, I =37.1%, n=14). The findings show that dietary ALA intake is associated with a reduced risk of mortality from all causes, CVD, and CHD, and a slightly higher risk of cancer mortality, whereas higher blood levels of ALA are associated with a reduced risk of all cause and CHD mortality only. PROSPERO CRD42021229487. |
| Author | Mobarak, Sara Asadi, Masoomeh Beyene, Joseph Aune, Dagfinn Naghshi, Sina Sadeghi, Omid |
| Author_xml | – sequence: 1 givenname: Sina surname: Naghshi fullname: Naghshi, Sina organization: Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Dagfinn surname: Aune fullname: Aune, Dagfinn organization: Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden – sequence: 3 givenname: Joseph surname: Beyene fullname: Beyene, Joseph organization: Chanchlani Research Centre, McMaster University, Hamilton, ON, Canada – sequence: 4 givenname: Sara surname: Mobarak fullname: Mobarak, Sara organization: Abadan University of Medical Sciences, Abadan, Iran – sequence: 5 givenname: Masoomeh surname: Asadi fullname: Asadi, Masoomeh organization: Department of Operating Room Nursing, Abadan University of Medical Sciences, Abadan, Iran – sequence: 6 givenname: Omid orcidid: 0000-0002-1029-1652 surname: Sadeghi fullname: Sadeghi, Omid email: omidsadeghi69@yahoo.com organization: Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34645650$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkt9qFDEUxgep2Fp74QtIQIQKnTaZTGYyXgil_oWCN3odzmbOuNnNJNsks7Iv5vOZ3W1LrV6dQ_I7Xz5OvufFgfMOi-Ilo-eM8eZiNi7OXVUx_qQ4Yq1oSiY5P3jQHxYnMS4opRVvZdeIZ8Uhr5taNIIeFb8_GEwQNsS4BEsk4HoyM36EsMQQiR8I2NUciDXOW3RGE9Cm32HBxOUesETDFPEsl9Abv4aoJwvhbIdpcBoDGX1IYE3avCNxExOOkLJYwLXBXzuu9xHLgHHlXUQyZlclOLCbaHY2tJ9nBRLT1BuML4qnA9iIJ7f1uPjx6eP3qy_l9bfPX68ur8uZ4G0qgSGlje6YrtuhHQbRVnImczNoLnVHddf1nLMaRdu0PQhNqwr6WkuoeyYGxo-L93vd1TQbsdfoUgCrVsHkDW2UB6P-vnFmrn76tZKCcUF5Fji9FQj-ZsKY1GiiRmvBoZ-iqoSsGJVNs33r9SN04aeQV7ClOi472rUyU68eOrq3cvelGbjYAzr4GAMOSpuUl-23Bo1VjKptblTOjdrlJk-8fTRxJ_o_9s2e3R7d-_uX-wNfpNQZ |
| CitedBy_id | crossref_primary_10_3390_ijms241814383 crossref_primary_10_1186_s43014_023_00217_1 crossref_primary_10_3390_metabo13050615 crossref_primary_10_3389_fimmu_2024_1297298 crossref_primary_10_1016_j_nut_2024_112358 crossref_primary_10_1080_10408398_2023_2251583 crossref_primary_10_1093_advances_nmac049 crossref_primary_10_1016_j_ajcnut_2024_11_029 crossref_primary_10_1007_s00394_025_03739_1 crossref_primary_10_1186_s12902_023_01412_4 crossref_primary_10_3390_antiox12050982 crossref_primary_10_1016_j_tifs_2022_08_002 crossref_primary_10_1016_j_nutres_2024_09_003 crossref_primary_10_1186_s40246_024_00591_y crossref_primary_10_1016_j_tifs_2022_10_011 crossref_primary_10_3390_foods14091566 crossref_primary_10_1002_fsn3_4405 crossref_primary_10_1016_j_prostaglandins_2023_106704 crossref_primary_10_1016_j_heliyon_2024_e39810 crossref_primary_10_1093_nutrit_nuad054 crossref_primary_10_1016_j_ecoenv_2023_115182 crossref_primary_10_1136_bmj_n2379 crossref_primary_10_3389_fphar_2024_1437760 crossref_primary_10_1016_j_annepidem_2022_10_015 crossref_primary_10_3390_foods12163005 crossref_primary_10_1016_j_jsbmb_2025_106677 crossref_primary_10_3389_fnut_2022_970364 crossref_primary_10_3389_fnmol_2024_1398665 crossref_primary_10_1016_j_antiviral_2023_105666 crossref_primary_10_3390_nu16244325 crossref_primary_10_1002_efd2_70039 crossref_primary_10_3390_app14041372 crossref_primary_10_3390_foods14040704 crossref_primary_10_1007_s40120_023_00477_6 crossref_primary_10_1111_ijfs_16158 crossref_primary_10_3390_ani12091113 crossref_primary_10_1186_s40543_025_00486_0 crossref_primary_10_1038_s41388_024_03073_6 crossref_primary_10_3390_ijerph19031256 crossref_primary_10_2147_VHRM_S379874 crossref_primary_10_1111_1753_0407_70110 crossref_primary_10_1007_s11906_023_01243_7 crossref_primary_10_1016_j_biopha_2025_118567 crossref_primary_10_1016_j_cnd_2025_02_004 crossref_primary_10_3390_foods13172739 crossref_primary_10_3389_fphar_2022_882197 crossref_primary_10_1016_j_micres_2024_127773 crossref_primary_10_1016_j_cdnut_2024_104407 crossref_primary_10_1016_j_clnesp_2022_02_001 crossref_primary_10_3389_fnut_2023_1079407 crossref_primary_10_1007_s13668_024_00547_7 crossref_primary_10_1016_j_archger_2023_105230 crossref_primary_10_1016_j_ajcnut_2024_11_012 crossref_primary_10_1080_10408398_2023_2200840 crossref_primary_10_1186_s12986_023_00753_0 crossref_primary_10_3389_fendo_2022_968984 crossref_primary_10_3390_ijms25094909 crossref_primary_10_3390_ijms26167776 crossref_primary_10_3390_foods13081167 crossref_primary_10_1016_j_clnu_2023_09_011 crossref_primary_10_1111_eci_14382 crossref_primary_10_3390_ijms24076110 crossref_primary_10_3390_molecules27092741 crossref_primary_10_1007_s13668_025_00639_y crossref_primary_10_3390_app12073599 crossref_primary_10_3390_nu16132071 crossref_primary_10_3389_fcvm_2021_788452 crossref_primary_10_1186_s12888_023_04715_x crossref_primary_10_3390_nu17152419 crossref_primary_10_3389_fnut_2022_1060436 crossref_primary_10_3390_nu15204461 crossref_primary_10_3389_fnut_2024_1335538 crossref_primary_10_1161_CIRCULATIONAHA_123_065530 crossref_primary_10_3390_nu16193379 crossref_primary_10_1016_j_jspr_2022_102059 crossref_primary_10_3390_ani12233362 crossref_primary_10_1016_j_advnut_2023_09_010 crossref_primary_10_3390_foods13091405 crossref_primary_10_1097_JN9_0000000000000046 crossref_primary_10_1016_j_jlr_2023_100493 crossref_primary_10_1097_MCO_0000000000001006 crossref_primary_10_3390_molecules29040754 crossref_primary_10_1186_s13643_023_02209_1 crossref_primary_10_3390_molecules27144471 crossref_primary_10_1038_s41387_024_00262_w crossref_primary_10_1038_s41598_024_78486_0 crossref_primary_10_1016_j_numecd_2023_02_025 crossref_primary_10_3390_nu14020239 |
| Cites_doi | 10.1016/j.clnu.2018.02.019 10.1186/1471-2288-14-70 10.1016/S0140-6736(14)60648-6 10.1093/ajcn/80.1.204 10.1016/j.nutres.2016.09.006 10.1080/17512433.2017.1333902 10.1055/s-0038-1642387 10.1177/1536867X0600600103 10.3181/00379727-200-43413 10.1161/CIRCOUTCOMES.109.896159 10.1093/ndt/gfs132 10.1093/ajcn/88.1.203 10.1016/j.atherosclerosis.2016.06.049 10.1001/jama.279.18.1477 10.1017/S0007114517003294 10.3945/an.114.006940 10.1161/CIRCULATIONAHA.115.015607 10.1161/JAHA.120.017401 10.1038/s41467-021-22370-2 10.1093/ajcn/nqz349 10.1001/archinte.165.2.193 10.3945/ajcn.110.009977 10.1136/bmj.g7647 10.1038/s41416-020-0761-6 10.1093/ajcn/69.5.890 10.1146/annurev-food-111317-095850 10.1161/CIRCRESAHA.118.314038 10.1194/jlr.R055095 10.3945/ajcn.115.127019 10.1016/j.jacl.2016.12.013 10.1158/1055-9965.EPI-18-0940 10.1002/cncr.29329 10.1016/j.clnu.2019.02.030 10.1136/bmj.l4009 10.1136/bmj.327.7414.557 10.1093/ajcn/74.4.457 10.1016/S0140-6736(10)60484-9 10.3945/ajcn.112.044040 10.1001/jamainternmed.2016.2925 10.1159/000419291 10.1136/bmj.313.7049.84 10.1016/j.fitote.2017.09.015 10.1001/jamainternmed.2013.6536 10.1016/j.clnu.2020.03.028 10.3945/ajcn.2009.26736E 10.1002/ijc.32233 10.1016/j.jacl.2018.02.010 10.1093/ajcn/78.1.65 10.1016/j.metabol.2008.11.013 10.1186/1741-7015-11-164 10.1001/jamainternmed.2016.2417 10.1038/nrcardio.2017.154 10.1093/ajcn/88.3.722 10.1016/j.amepre.2016.07.020 10.1016/j.lfs.2018.04.049 10.1002/ijc.29210 10.1161/CIRCULATIONAHA.105.572008 10.1002/ijc.31247 10.1093/aje/kwr520 10.1002/pros.24027 doi:10.1093/oxfordjournals.aje.a116237 10.1093/aje/kwh307 10.3390/nu11122974 10.1016/j.ijcard.2012.09.076 10.1038/sj.ejcn.1602408 10.1097/00001648-200007000-00013 10.1161/JAHA.115.002543 10.1186/1476-511X-13-196 10.1093/ije/30.5.1119 10.1080/10408398.2013.828678 10.1016/j.phrs.2016.09.040 10.1186/s13643-018-0915-2 10.1093/ajcn/77.2.319 10.1186/s12916-016-0730-3 10.1016/j.cct.2015.09.002 10.1001/jamacardio.2016.2259 10.1016/j.nut.2019.110610 10.1371/journal.pone.0059408 10.1093/oxfordjournals.aje.a009047 10.1158/1055-9965.EPI-12-1196-T 10.1093/jn/134.4.919 10.1093/oxfordjournals.aje.a009710 10.1016/S0002-8223(02)90346-9 10.1016/j.jacc.2020.08.073 10.1002/14651858.CD003177.pub3 10.1017/S000711451400138X 10.1097/MCO.0000000000000439 10.1017/S0007114514001925 10.1177/2047487313517576 10.3181/0711-MR-311 10.1177/1534735416656052 |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ |
| DBID | 9YT ACMMV AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88I 8AF 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 ASE AZQEC BBNVY BENPR BHPHI BTHHO CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH HCIFZ K6X K9. KB0 LK8 M2O M2P M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
| DOI | 10.1136/bmj.n2213 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) STEM Database ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection BMJ Journals ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library SciTech Premium Collection British Nursing Index ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Research Library Science Database Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium Proquest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest AP Science ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Research Library ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition British Nursing Index with Full Text British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition BMJ Journals ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Research Library Prep MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1756-1833 |
| ExternalDocumentID | PMC8513503 34645650 10_1136_bmj_n2213 bmj |
| Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
| GroupedDBID | 23N 39C 4.4 40O 53G 5GY 7RV 7X7 88I 8AF 8F7 8FE 8FH 8FI 8FJ 8G5 9YT AACGO AANCE AAWJN ABIVO ABJNI ABPLY ABTLG ABUWG ABVAJ ACGFS ACGOD ACMFJ ACMMV ACPRK AFKRA AGFXO AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BBNVY BENPR BHPHI BPHCQ BTHHO C45 CCPQU CS3 DWQXO EBS EJD F5P FYUFA GNUQQ GUQSH H13 HAJ HCIFZ HMCUK HZ~ JLS JSG JST L7B LK8 M2O M2P M7P NAPCQ NXWIF O9- OVD PHGZT PQQKQ PROAC R53 RHI RMJ RV8 TEORI UKHRP VVN WOQ YFH YQY AAYXX ABBHK AEUPB AEXZC AFFHD AN0 CITATION DCCCD IAG IBB IMI IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLXEF JPM PHGZM PJZUB PPXIY PQGLB SA0 0R~ CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK ASE FPQ K6X K9. MBDVC PKEHL PQEST PQUKI PRINS PUEGO Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-b537t-a1e006c91c47f7ff5728b87fffc38c90c99d3314e5767da5c022ad4c8a4d15f13 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 131 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000708090000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-1833 0959-8138 |
| IngestDate | Tue Nov 04 02:00:40 EST 2025 Wed Oct 01 14:10:53 EDT 2025 Mon Sep 08 13:53:42 EDT 2025 Thu Apr 03 06:53:15 EDT 2025 Sat Nov 29 04:10:51 EST 2025 Tue Nov 18 22:09:21 EST 2025 Thu Apr 24 22:49:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b537t-a1e006c91c47f7ff5728b87fffc38c90c99d3314e5767da5c022ad4c8a4d15f13 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| ORCID | 0000-0002-1029-1652 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8513503 |
| PMID | 34645650 |
| PQID | 2593890978 |
| PQPubID | 2043523 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8513503 proquest_miscellaneous_2582108661 proquest_journals_2593890978 pubmed_primary_34645650 crossref_citationtrail_10_1136_bmj_n2213 crossref_primary_10_1136_bmj_n2213 bmj_journals_10_1136_bmj_n2213 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-13 |
| PublicationDateYYYYMMDD | 2021-10-13 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMJ (Online) |
| PublicationTitleAbbrev | BMJ |
| PublicationTitleAlternate | BMJ |
| PublicationYear | 2021 |
| Publisher | British Medical Journal Publishing Group BMJ Publishing Group LTD BMJ Publishing Group Ltd |
| Publisher_xml | – name: British Medical Journal Publishing Group – name: BMJ Publishing Group LTD – name: BMJ Publishing Group Ltd |
| References | Stark, Reifen, Crawford (ref11) 2016; 56 DerSimonian, Laird (ref61) 2015; 45 Marklund, Leander, Vikström (ref28) 2015; 132 Zhuang, Zhang, He (ref37) 2019; 124 Pottala, Garg, Cohen, Whooley, Harris (ref31) 2010; 3 Kumar, Contaifer, Madurantakam (ref9) 2019; 11 Laaksonen, Nyyssönen, Niskanen, Rissanen, Salonen (ref25) 2005; 165 Saini, Keum (ref86) 2018; 203 Shamseer, Moher, Clarke (ref58) 2015; 350 Aucoin, Cooley, Knee (ref6) 2017; 16 Sala-Vila, Guasch-Ferré, Hu (ref38) 2016; 5 Balakumar, Maung-U, Jagadeesh (ref2) 2016; 113 Shahidi, Ambigaipalan (ref10) 2018; 9 Huang, Stenvinkel, Qureshi (ref70) 2012; 27 Vedtofte, Jakobsen, Lauritzen (ref42) 2014; 112 Danesh, Collins, Appleby, Peto (ref60) 1998; 279 Koh, Pan, Wang (ref24) 2015; 22 Albert, Oh, Whang (ref43) 2005; 112 Abudurexiti, Zhu, Wang (ref67) 2020; 80 Serini, Calviello (ref90) 2018; 21 Greenland, Longnecker (ref68) 1992; 135 Kleber, Delgado, Lorkowski, März, von Schacky (ref49) 2016; 252 Khankari, Bradshaw, Steck (ref23) 2015; 121 Andersson, Vasan (ref1) 2018; 15 Fretts, Mozaffarian, Siscovick (ref20) 2014; 112 Hanson, Thorpe, Winstanley, Abdelhamid, Hooper (ref89) 2020; 122 Jayanama, Theou, Godin, Cahill, Rockwood (ref50) 2020; 70 Bauer, Briss, Goodman, Bowman (ref3) 2014; 384 Harris, Tintle, Imamura (ref54) 2021; 12 Higgins, Thompson, Deeks, Altman (ref65) 2003; 327 Lemaitre, King, Mozaffarian, Kuller, Tracy, Siscovick (ref80) 2003; 77 Rhee, Kim, Buring, Kurth (ref46) 2017; 52 Orsini, Bellocco, Greenland (ref69) 2006; 6 Goyens, Mensink (ref88) 2006; 60 Wei, Hou, Xi (ref55) 2018; 119 Simon, Chen, Bent (ref56) 2009; 89 de Goede, Verschuren, Boer, Verberne, Kromhout, Geleijnse (ref15) 2013; 8 Harris, Kennedy, O’Keefe, Spertus (ref52) 2013; 168 Bero, Chartres, Diong (ref59) 2018; 7 Kilander, Berglund, Boberg, Vessby, Lithell (ref76) 2001; 30 Trumbo, Schlicker, Yates, Poos (ref93) 2002; 102 Freese, Mutanen, Valsta, Salminen (ref87) 1994; 71 Mori (ref4) 2017; 123 Pietinen, Ascherio, Korhonen (ref30) 1997; 145 Watanabe, Tatsuno (ref5) 2017; 10 Zelniker, Morrow, Scirica (ref71) 2021; 10 Wang, Li, Chiuve (ref34) 2016; 176 Miura, Hughes, Ungerer, Green (ref39) 2016; 36 Dolecek (ref75) 1992; 200 Oomen, Ocké, Feskens, Kok, Kromhout (ref29) 2001; 74 Sarwar, Gao, Seshasai (ref63) 2010; 375 Epstein, Kasperzyk, Mucci (ref17) 2012; 176 Leitzmann, Stampfer, Michaud (ref79) 2004; 80 Richman, Kenfield, Chavarro (ref32) 2013; 173 Warensjö, Sundström, Vessby, Cederholm, Risérus (ref35) 2008; 88 Perez-Cornago, Huybrechts, Appleby (ref53) 2020; 146 Lelli, Antonelli Incalzi, Ferrucci, Bandinelli, Pedone (ref26) 2020; 39 Jiao, Liu, Shin (ref22) 2019; 366 Simon, Fong, Bernert, Browner (ref33) 1998; 148 Pelser, Mondul, Hollenbeck, Park (ref45) 2013; 22 Aune, Keum, Giovannucci (ref91) 2016; 14 Lemaitre, King, Sotoodehnia (ref72) 2009; 58 Dolecek, Granditis (ref16) 1991; 66 Brouwer, Katan, Zock (ref57) 2004; 134 Zhuang, Wang, Wang, Zhang, Jiao (ref36) 2019; 38 Ferlay, Soerjomataram, Dikshit (ref64) 2015; 136 Fortes, Forastiere, Farchi, Rapiti, Pastori, Perucci (ref19) 2000; 11 Abdelhamid, Brown, Brainard (ref85) 2018; 7 Del Gobbo, Imamura, Aslibekyan (ref41) 2016; 176 van Enst, Ochodo, Scholten, Hooft, Leeflang (ref66) 2014; 14 Ascherio, Rimm, Giovannucci, Spiegelman, Stampfer, Willett (ref44) 1996; 313 Mazidi, Mikhailidis, Sattar (ref82) 2020; 39 Mozaffarian (ref13) 2005; 11 Folsom, Demissie (ref74) 2004; 160 Fritsche (ref7) 2015; 6 Harris, Luo, Pottala (ref21) 2017; 11 Spector, Kim (ref8) 2015; 56 Hu, Stampfer, Manson (ref77) 1999; 69 Lindberg, Saltvedt, Sletvold, Bjerve (ref27) 2008; 88 Harris, Tintle, Etherton, Vasan (ref48) 2018; 12 Liyanage, Ong, An, Gharahkhani, Law, MacGregor (ref73) 2019; 28 Wu, Wilson, Stampfer, Willett, Giovannucci (ref78) 2018; 142 Bork, Jakobsen, Lundbye-Christensen, Tjønneland, Schmidt, Overvad (ref14) 2016; 104 Borenstein, Hedges, Higgins (ref62) 2009; 77 Pan, Chen, Chowdhury (ref81) 2012; 96 Erkkilä, Lehto, Pyörälä, Uusitupa (ref18) 2003; 78 Gopinath, Buyken, Flood, Empson, Rochtchina, Mitchell (ref40) 2011; 93 Iggman, Ärnlöv, Cederholm, Risérus (ref47) 2016; 1 Li, Guasch-Ferré, Li, Hu (ref83) 2020; 112 Guasch-Ferré, Bulló, Martínez-González (ref92) 2013; 11 Lázaro, Rueda, Cediel (ref51) 2020; 76 Simopoulos (ref84) 2008; 233 Lee, Ivester, Hester (ref12) 2014; 13 2023030804355048000_375.oct13_9.n2213.73 2023030804355048000_375.oct13_9.n2213.72 2023030804355048000_375.oct13_9.n2213.71 2023030804355048000_375.oct13_9.n2213.70 2023030804355048000_375.oct13_9.n2213.37 2023030804355048000_375.oct13_9.n2213.36 2023030804355048000_375.oct13_9.n2213.35 2023030804355048000_375.oct13_9.n2213.79 2023030804355048000_375.oct13_9.n2213.34 2023030804355048000_375.oct13_9.n2213.78 2023030804355048000_375.oct13_9.n2213.33 2023030804355048000_375.oct13_9.n2213.77 2023030804355048000_375.oct13_9.n2213.32 2023030804355048000_375.oct13_9.n2213.76 2023030804355048000_375.oct13_9.n2213.31 2023030804355048000_375.oct13_9.n2213.75 2023030804355048000_375.oct13_9.n2213.30 2023030804355048000_375.oct13_9.n2213.74 2023030804355048000_375.oct13_9.n2213.39 2023030804355048000_375.oct13_9.n2213.38 2023030804355048000_375.oct13_9.n2213.61 2023030804355048000_375.oct13_9.n2213.60 Mozaffarian (2023030804355048000_375.oct13_9.n2213.13) 2005; 11 2023030804355048000_375.oct13_9.n2213.26 2023030804355048000_375.oct13_9.n2213.25 2023030804355048000_375.oct13_9.n2213.69 2023030804355048000_375.oct13_9.n2213.24 2023030804355048000_375.oct13_9.n2213.68 2023030804355048000_375.oct13_9.n2213.23 2023030804355048000_375.oct13_9.n2213.67 2023030804355048000_375.oct13_9.n2213.22 2023030804355048000_375.oct13_9.n2213.66 2023030804355048000_375.oct13_9.n2213.21 2023030804355048000_375.oct13_9.n2213.65 2023030804355048000_375.oct13_9.n2213.20 2023030804355048000_375.oct13_9.n2213.64 2023030804355048000_375.oct13_9.n2213.63 2023030804355048000_375.oct13_9.n2213.29 2023030804355048000_375.oct13_9.n2213.28 2023030804355048000_375.oct13_9.n2213.27 2023030804355048000_375.oct13_9.n2213.2 2023030804355048000_375.oct13_9.n2213.51 2023030804355048000_375.oct13_9.n2213.1 2023030804355048000_375.oct13_9.n2213.50 2023030804355048000_375.oct13_9.n2213.93 2023030804355048000_375.oct13_9.n2213.92 2023030804355048000_375.oct13_9.n2213.91 2023030804355048000_375.oct13_9.n2213.90 2023030804355048000_375.oct13_9.n2213.15 2023030804355048000_375.oct13_9.n2213.59 2023030804355048000_375.oct13_9.n2213.9 2023030804355048000_375.oct13_9.n2213.14 2023030804355048000_375.oct13_9.n2213.58 2023030804355048000_375.oct13_9.n2213.8 2023030804355048000_375.oct13_9.n2213.57 2023030804355048000_375.oct13_9.n2213.7 2023030804355048000_375.oct13_9.n2213.12 2023030804355048000_375.oct13_9.n2213.56 2023030804355048000_375.oct13_9.n2213.6 2023030804355048000_375.oct13_9.n2213.11 2023030804355048000_375.oct13_9.n2213.55 Borenstein (2023030804355048000_375.oct13_9.n2213.62) 2009; 77 2023030804355048000_375.oct13_9.n2213.5 2023030804355048000_375.oct13_9.n2213.10 2023030804355048000_375.oct13_9.n2213.54 2023030804355048000_375.oct13_9.n2213.4 2023030804355048000_375.oct13_9.n2213.53 2023030804355048000_375.oct13_9.n2213.3 2023030804355048000_375.oct13_9.n2213.52 2023030804355048000_375.oct13_9.n2213.19 2023030804355048000_375.oct13_9.n2213.18 2023030804355048000_375.oct13_9.n2213.17 2023030804355048000_375.oct13_9.n2213.16 2023030804355048000_375.oct13_9.n2213.40 2023030804355048000_375.oct13_9.n2213.84 2023030804355048000_375.oct13_9.n2213.83 2023030804355048000_375.oct13_9.n2213.82 2023030804355048000_375.oct13_9.n2213.81 2023030804355048000_375.oct13_9.n2213.80 2023030804355048000_375.oct13_9.n2213.48 2023030804355048000_375.oct13_9.n2213.47 2023030804355048000_375.oct13_9.n2213.46 2023030804355048000_375.oct13_9.n2213.45 2023030804355048000_375.oct13_9.n2213.89 2023030804355048000_375.oct13_9.n2213.44 2023030804355048000_375.oct13_9.n2213.88 2023030804355048000_375.oct13_9.n2213.43 2023030804355048000_375.oct13_9.n2213.87 2023030804355048000_375.oct13_9.n2213.42 2023030804355048000_375.oct13_9.n2213.86 2023030804355048000_375.oct13_9.n2213.41 2023030804355048000_375.oct13_9.n2213.85 2023030804355048000_375.oct13_9.n2213.49 |
| References_xml | – volume: 76 start-page: 2089 year: 2020 ident: ref51 article-title: Circulating Omega-3 Fatty Acids and Incident Adverse Events in Patients With Acute Myocardial Infarction publication-title: J Am Coll Cardiol – volume: 27 start-page: 3615 year: 2012 ident: ref70 article-title: Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients publication-title: Nephrol Dial Transplant – volume: 39 start-page: 510 year: 2020 ident: ref26 article-title: Association between PUFA intake and serum concentration and mortality in older adults: A cohort study publication-title: Clin Nutr – volume: 11 start-page: 24 year: 2005 ident: ref13 article-title: Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence publication-title: Altern Ther Health Med – volume: 77 start-page: 319 year: 2003 ident: ref80 article-title: n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study publication-title: Am J Clin Nutr – volume: 22 start-page: 364 year: 2015 ident: ref24 article-title: The association between dietary omega-3 fatty acids and cardiovascular death: the Singapore Chinese Health Study publication-title: Eur J Prev Cardiol – volume: 279 start-page: 1477 year: 1998 ident: ref60 article-title: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies publication-title: JAMA – volume: 14 start-page: 70 year: 2014 ident: ref66 article-title: Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study publication-title: BMC Med Res Methodol – volume: 69 start-page: 890 year: 1999 ident: ref77 article-title: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women publication-title: Am J Clin Nutr – volume: 6 start-page: 293S year: 2015 ident: ref7 article-title: The science of fatty acids and inflammation publication-title: Adv Nutr – volume: 148 start-page: 854 year: 1998 ident: ref33 article-title: Serum fatty acids and the risk of fatal cancer. MRFIT Research Group. Multiple Risk Factor Intervention Trial publication-title: Am J Epidemiol – volume: 8 year: 2013 ident: ref15 article-title: N-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysis publication-title: PLoS One – volume: 176 start-page: 1134 year: 2016 ident: ref34 article-title: Association of Specific Dietary Fats With Total and Cause-Specific Mortality publication-title: JAMA Intern Med – volume: 80 start-page: 204 year: 2004 ident: ref79 article-title: Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer publication-title: Am J Clin Nutr – volume: 52 start-page: 10 year: 2017 ident: ref46 article-title: Fish Consumption, Omega-3 Fatty Acids, and Risk of Cardiovascular Disease publication-title: Am J Prev Med – volume: 313 start-page: 84 year: 1996 ident: ref44 article-title: Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States publication-title: BMJ – volume: 38 start-page: 848 year: 2019 ident: ref36 article-title: Polyunsaturated fatty acids intake, omega-6/omega-3 ratio and mortality: Findings from two independent nationwide cohorts publication-title: Clin Nutr – volume: 112 start-page: 3232 year: 2005 ident: ref43 article-title: Dietary alpha-linolenic acid intake and risk of sudden cardiac death and coronary heart disease publication-title: Circulation – volume: 350 start-page: g7647 year: 2015 ident: ref58 article-title: Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation publication-title: BMJ – volume: 7 start-page: 242 year: 2018 ident: ref59 article-title: The risk of bias in observational studies of exposures (ROBINS-E) tool: concerns arising from application to observational studies of exposures publication-title: Syst Rev – volume: 375 start-page: 2215 year: 2010 ident: ref63 article-title: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies publication-title: Lancet – volume: 96 start-page: 1262 year: 2012 ident: ref81 article-title: α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis publication-title: Am J Clin Nutr – volume: 142 start-page: 2207 year: 2018 ident: ref78 article-title: A 24-year prospective study of dietary α-linolenic acid and lethal prostate cancer publication-title: Int J Cancer – volume: 93 start-page: 1073 year: 2011 ident: ref40 article-title: Consumption of polyunsaturated fatty acids, fish, and nuts and risk of inflammatory disease mortality publication-title: Am J Clin Nutr – volume: 28 start-page: 1015 year: 2019 ident: ref73 article-title: Mendelian Randomization Study for Genetically Predicted Polyunsaturated Fatty Acids Levels on Overall Cancer Risk and Mortality publication-title: Cancer Epidemiol Biomarkers Prev – volume: 12 start-page: 718 year: 2018 ident: ref48 article-title: Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart Study publication-title: J Clin Lipidol – volume: 132 start-page: 586 year: 2015 ident: ref28 article-title: Polyunsaturated Fat Intake Estimated by Circulating Biomarkers and Risk of Cardiovascular Disease and All-Cause Mortality in a Population-Based Cohort of 60-Year-Old Men and Women publication-title: Circulation – volume: 21 start-page: 83 year: 2018 ident: ref90 article-title: Long-chain omega-3 fatty acids and cancer: any cause for concern? publication-title: Curr Opin Clin Nutr Metab Care – volume: 45 start-page: 139 year: 2015 ident: ref61 article-title: Meta-analysis in clinical trials revisited publication-title: Contemp Clin Trials – volume: 14 start-page: 207 year: 2016 ident: ref91 article-title: Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies publication-title: BMC Med – volume: 10 start-page: 865 year: 2017 ident: ref5 article-title: Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future publication-title: Expert Rev Clin Pharmacol – volume: 71 start-page: 73 year: 1994 ident: ref87 article-title: Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation publication-title: Thromb Haemost – volume: 11 start-page: 440 year: 2000 ident: ref19 article-title: Diet and overall survival in a cohort of very elderly people publication-title: Epidemiology – volume: 176 start-page: 1155 year: 2016 ident: ref41 article-title: ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies publication-title: JAMA Intern Med – volume: 11 year: 2019 ident: ref9 article-title: Dietary Bioactive Fatty Acids as Modulators of Immune Function: Implications on Human Health publication-title: Nutrients – volume: 56 start-page: 2261 year: 2016 ident: ref11 article-title: Past and Present Insights on Alpha-linolenic Acid and the Omega-3 Fatty Acid Family publication-title: Crit Rev Food Sci Nutr – volume: 78 start-page: 65 year: 2003 ident: ref18 article-title: n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease publication-title: Am J Clin Nutr – volume: 22 start-page: 697 year: 2013 ident: ref45 article-title: Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study publication-title: Cancer Epidemiol Biomarkers Prev – volume: 168 start-page: 53 year: 2013 ident: ref52 article-title: Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarction publication-title: Int J Cardiol – volume: 36 start-page: 1202 year: 2016 ident: ref39 article-title: Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study publication-title: Nutr Res – volume: 88 start-page: 722 year: 2008 ident: ref27 article-title: Long-chain n-3 fatty acids and mortality in elderly patients publication-title: Am J Clin Nutr – volume: 203 start-page: 255 year: 2018 ident: ref86 article-title: Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review publication-title: Life Sci – volume: 70 year: 2020 ident: ref50 article-title: Association of fatty acid consumption with frailty and mortality among middle-aged and older adults publication-title: Nutrition – volume: 136 start-page: E359 year: 2015 ident: ref64 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer – volume: 11 start-page: 164 year: 2013 ident: ref92 article-title: Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial publication-title: BMC Med – volume: 88 start-page: 203 year: 2008 ident: ref35 article-title: Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study publication-title: Am J Clin Nutr – volume: 384 start-page: 45 year: 2014 ident: ref3 article-title: Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA publication-title: Lancet – volume: 89 start-page: 1558S year: 2009 ident: ref56 article-title: The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysis publication-title: Am J Clin Nutr – volume: 66 start-page: 205 year: 1991 ident: ref16 article-title: Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT) publication-title: World Rev Nutr Diet – volume: 112 start-page: 150 year: 2020 ident: ref83 article-title: Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies publication-title: Am J Clin Nutr – volume: 56 start-page: 11 year: 2015 ident: ref8 article-title: Discovery of essential fatty acids publication-title: J Lipid Res – volume: 74 start-page: 457 year: 2001 ident: ref29 article-title: alpha-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study publication-title: Am J Clin Nutr – volume: 58 start-page: 534 year: 2009 ident: ref72 article-title: Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest publication-title: Metabolism – volume: 104 start-page: 41 year: 2016 ident: ref14 article-title: Dietary intake and adipose tissue content of α-linolenic acid and risk of myocardial infarction: a Danish cohort study publication-title: Am J Clin Nutr – volume: 1 start-page: 745 year: 2016 ident: ref47 article-title: Association of Adipose Tissue Fatty Acids With Cardiovascular and All-Cause Mortality in Elderly Men publication-title: JAMA Cardiol – volume: 200 start-page: 177 year: 1992 ident: ref75 article-title: Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial publication-title: Proc Soc Exp Biol Med – volume: 60 start-page: 978 year: 2006 ident: ref88 article-title: Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects publication-title: Eur J Clin Nutr – volume: 176 start-page: 240 year: 2012 ident: ref17 article-title: Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden publication-title: Am J Epidemiol – volume: 160 start-page: 1005 year: 2004 ident: ref74 article-title: Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women publication-title: Am J Epidemiol – volume: 5 year: 2016 ident: ref38 article-title: Dietary α-Linolenic Acid, Marine ω-3 Fatty Acids, and Mortality in a Population With High Fish Consumption: Findings From the PREvención con DIeta MEDiterránea (PREDIMED) Study publication-title: J Am Heart Assoc – volume: 233 start-page: 674 year: 2008 ident: ref84 article-title: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases publication-title: Exp Biol Med (Maywood) – volume: 119 start-page: 83 year: 2018 ident: ref55 article-title: The association and dose-response relationship between dietary intake of α-linolenic acid and risk of CHD: a systematic review and meta-analysis of cohort studies publication-title: Br J Nutr – volume: 124 start-page: 757 year: 2019 ident: ref37 article-title: Dietary Fats in Relation to Total and Cause-Specific Mortality in a Prospective Cohort of 521 120 Individuals With 16 Years of Follow-Up publication-title: Circ Res – volume: 252 start-page: 175 year: 2016 ident: ref49 article-title: Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study publication-title: Atherosclerosis – volume: 6 start-page: 40 year: 2006 ident: ref69 article-title: Generalized least squares for trend estimation of summarized dose–response data publication-title: Stata J – volume: 7 year: 2018 ident: ref85 article-title: Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease publication-title: Cochrane Database Syst Rev – volume: 112 start-page: 735 year: 2014 ident: ref42 article-title: Association between the intake of α-linolenic acid and the risk of CHD publication-title: Br J Nutr – volume: 77 start-page: 85 year: 2009 ident: ref62 article-title: Fixed-effect versus random-effects models publication-title: Introduction to Meta-analysis – volume: 113 start-page: 600 year: 2016 ident: ref2 article-title: Prevalence and prevention of cardiovascular disease and diabetes mellitus publication-title: Pharmacol Res – volume: 135 start-page: 1301 year: 1992 ident: ref68 article-title: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis publication-title: Am J Epidemiol – volume: 15 start-page: 230 year: 2018 ident: ref1 article-title: Epidemiology of cardiovascular disease in young individuals publication-title: Nat Rev Cardiol – volume: 173 start-page: 1318 year: 2013 ident: ref32 article-title: Fat intake after diagnosis and risk of lethal prostate cancer and all-cause mortality publication-title: JAMA Intern Med – volume: 327 start-page: 557 year: 2003 ident: ref65 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ – volume: 122 start-page: 1260 year: 2020 ident: ref89 article-title: Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials publication-title: Br J Cancer – volume: 102 start-page: 1621 year: 2002 ident: ref93 article-title: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids publication-title: J Am Diet Assoc – volume: 3 start-page: 406 year: 2010 ident: ref31 article-title: Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study publication-title: Circ Cardiovasc Qual Outcomes – volume: 123 start-page: 51 year: 2017 ident: ref4 article-title: Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease publication-title: Fitoterapia – volume: 121 start-page: 2244 year: 2015 ident: ref23 article-title: Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York publication-title: Cancer – volume: 165 start-page: 193 year: 2005 ident: ref25 article-title: Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids publication-title: Arch Intern Med – volume: 134 start-page: 919 year: 2004 ident: ref57 article-title: Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis publication-title: J Nutr – volume: 11 start-page: 250 year: 2017 ident: ref21 article-title: Red blood cell polyunsaturated fatty acids and mortality in the Women’s Health Initiative Memory Study publication-title: J Clin Lipidol – volume: 146 start-page: 44 year: 2020 ident: ref53 article-title: Intake of individual fatty acids and risk of prostate cancer in the European prospective investigation into cancer and nutrition publication-title: Int J Cancer – volume: 80 start-page: 950 year: 2020 ident: ref67 article-title: Targeting CPT1B as a potential therapeutic strategy in castration-resistant and enzalutamide-resistant prostate cancer publication-title: Prostate – volume: 366 start-page: l4009 year: 2019 ident: ref22 article-title: Dietary fats and mortality among patients with type 2 diabetes: analysis in two population based cohort studies publication-title: BMJ – volume: 12 start-page: 2329 year: 2021 ident: ref54 article-title: Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies publication-title: Nat Commun – volume: 9 start-page: 345 year: 2018 ident: ref10 article-title: Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits publication-title: Annu Rev Food Sci Technol – volume: 10 year: 2021 ident: ref71 article-title: Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36 publication-title: J Am Heart Assoc – volume: 145 start-page: 876 year: 1997 ident: ref30 article-title: Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study publication-title: Am J Epidemiol – volume: 16 start-page: 32 year: 2017 ident: ref6 article-title: Fish-Derived Omega-3 Fatty Acids and Prostate Cancer: A Systematic Review publication-title: Integr Cancer Ther – volume: 30 start-page: 1119 year: 2001 ident: ref76 article-title: Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men publication-title: Int J Epidemiol – volume: 13 start-page: 196 year: 2014 ident: ref12 article-title: The impact of polyunsaturated fatty acid-based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population publication-title: Lipids Health Dis – volume: 112 start-page: 1206 year: 2014 ident: ref20 article-title: Plasma phospholipid and dietary α-linolenic acid, mortality, CHD and stroke: the Cardiovascular Health Study publication-title: Br J Nutr – volume: 39 start-page: 3677 year: 2020 ident: ref82 article-title: Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective studies with 1,164,029 participants publication-title: Clin Nutr – ident: 2023030804355048000_375.oct13_9.n2213.36 doi: 10.1016/j.clnu.2018.02.019 – ident: 2023030804355048000_375.oct13_9.n2213.66 doi: 10.1186/1471-2288-14-70 – ident: 2023030804355048000_375.oct13_9.n2213.3 doi: 10.1016/S0140-6736(14)60648-6 – ident: 2023030804355048000_375.oct13_9.n2213.79 doi: 10.1093/ajcn/80.1.204 – ident: 2023030804355048000_375.oct13_9.n2213.39 doi: 10.1016/j.nutres.2016.09.006 – ident: 2023030804355048000_375.oct13_9.n2213.5 doi: 10.1080/17512433.2017.1333902 – ident: 2023030804355048000_375.oct13_9.n2213.87 doi: 10.1055/s-0038-1642387 – ident: 2023030804355048000_375.oct13_9.n2213.69 doi: 10.1177/1536867X0600600103 – ident: 2023030804355048000_375.oct13_9.n2213.75 doi: 10.3181/00379727-200-43413 – ident: 2023030804355048000_375.oct13_9.n2213.31 doi: 10.1161/CIRCOUTCOMES.109.896159 – ident: 2023030804355048000_375.oct13_9.n2213.70 doi: 10.1093/ndt/gfs132 – ident: 2023030804355048000_375.oct13_9.n2213.35 doi: 10.1093/ajcn/88.1.203 – ident: 2023030804355048000_375.oct13_9.n2213.49 doi: 10.1016/j.atherosclerosis.2016.06.049 – ident: 2023030804355048000_375.oct13_9.n2213.60 doi: 10.1001/jama.279.18.1477 – ident: 2023030804355048000_375.oct13_9.n2213.55 doi: 10.1017/S0007114517003294 – ident: 2023030804355048000_375.oct13_9.n2213.7 doi: 10.3945/an.114.006940 – ident: 2023030804355048000_375.oct13_9.n2213.28 doi: 10.1161/CIRCULATIONAHA.115.015607 – ident: 2023030804355048000_375.oct13_9.n2213.71 doi: 10.1161/JAHA.120.017401 – ident: 2023030804355048000_375.oct13_9.n2213.54 doi: 10.1038/s41467-021-22370-2 – ident: 2023030804355048000_375.oct13_9.n2213.83 doi: 10.1093/ajcn/nqz349 – ident: 2023030804355048000_375.oct13_9.n2213.25 doi: 10.1001/archinte.165.2.193 – ident: 2023030804355048000_375.oct13_9.n2213.40 doi: 10.3945/ajcn.110.009977 – ident: 2023030804355048000_375.oct13_9.n2213.58 doi: 10.1136/bmj.g7647 – ident: 2023030804355048000_375.oct13_9.n2213.89 doi: 10.1038/s41416-020-0761-6 – ident: 2023030804355048000_375.oct13_9.n2213.77 doi: 10.1093/ajcn/69.5.890 – ident: 2023030804355048000_375.oct13_9.n2213.10 doi: 10.1146/annurev-food-111317-095850 – ident: 2023030804355048000_375.oct13_9.n2213.37 doi: 10.1161/CIRCRESAHA.118.314038 – ident: 2023030804355048000_375.oct13_9.n2213.8 doi: 10.1194/jlr.R055095 – ident: 2023030804355048000_375.oct13_9.n2213.14 doi: 10.3945/ajcn.115.127019 – ident: 2023030804355048000_375.oct13_9.n2213.21 doi: 10.1016/j.jacl.2016.12.013 – ident: 2023030804355048000_375.oct13_9.n2213.73 doi: 10.1158/1055-9965.EPI-18-0940 – ident: 2023030804355048000_375.oct13_9.n2213.23 doi: 10.1002/cncr.29329 – ident: 2023030804355048000_375.oct13_9.n2213.26 doi: 10.1016/j.clnu.2019.02.030 – ident: 2023030804355048000_375.oct13_9.n2213.22 doi: 10.1136/bmj.l4009 – ident: 2023030804355048000_375.oct13_9.n2213.65 doi: 10.1136/bmj.327.7414.557 – ident: 2023030804355048000_375.oct13_9.n2213.29 doi: 10.1093/ajcn/74.4.457 – ident: 2023030804355048000_375.oct13_9.n2213.63 doi: 10.1016/S0140-6736(10)60484-9 – ident: 2023030804355048000_375.oct13_9.n2213.81 doi: 10.3945/ajcn.112.044040 – ident: 2023030804355048000_375.oct13_9.n2213.41 doi: 10.1001/jamainternmed.2016.2925 – ident: 2023030804355048000_375.oct13_9.n2213.16 doi: 10.1159/000419291 – ident: 2023030804355048000_375.oct13_9.n2213.44 doi: 10.1136/bmj.313.7049.84 – ident: 2023030804355048000_375.oct13_9.n2213.4 doi: 10.1016/j.fitote.2017.09.015 – ident: 2023030804355048000_375.oct13_9.n2213.32 doi: 10.1001/jamainternmed.2013.6536 – ident: 2023030804355048000_375.oct13_9.n2213.82 doi: 10.1016/j.clnu.2020.03.028 – ident: 2023030804355048000_375.oct13_9.n2213.56 doi: 10.3945/ajcn.2009.26736E – volume: 77 start-page: 85 year: 2009 ident: 2023030804355048000_375.oct13_9.n2213.62 article-title: Fixed-effect versus random-effects models publication-title: Introduction to Meta-analysis – ident: 2023030804355048000_375.oct13_9.n2213.53 doi: 10.1002/ijc.32233 – ident: 2023030804355048000_375.oct13_9.n2213.48 doi: 10.1016/j.jacl.2018.02.010 – ident: 2023030804355048000_375.oct13_9.n2213.18 doi: 10.1093/ajcn/78.1.65 – ident: 2023030804355048000_375.oct13_9.n2213.72 doi: 10.1016/j.metabol.2008.11.013 – ident: 2023030804355048000_375.oct13_9.n2213.92 doi: 10.1186/1741-7015-11-164 – ident: 2023030804355048000_375.oct13_9.n2213.34 doi: 10.1001/jamainternmed.2016.2417 – ident: 2023030804355048000_375.oct13_9.n2213.1 doi: 10.1038/nrcardio.2017.154 – ident: 2023030804355048000_375.oct13_9.n2213.27 doi: 10.1093/ajcn/88.3.722 – ident: 2023030804355048000_375.oct13_9.n2213.46 doi: 10.1016/j.amepre.2016.07.020 – ident: 2023030804355048000_375.oct13_9.n2213.86 doi: 10.1016/j.lfs.2018.04.049 – ident: 2023030804355048000_375.oct13_9.n2213.64 doi: 10.1002/ijc.29210 – ident: 2023030804355048000_375.oct13_9.n2213.43 doi: 10.1161/CIRCULATIONAHA.105.572008 – ident: 2023030804355048000_375.oct13_9.n2213.78 doi: 10.1002/ijc.31247 – ident: 2023030804355048000_375.oct13_9.n2213.17 doi: 10.1093/aje/kwr520 – ident: 2023030804355048000_375.oct13_9.n2213.67 doi: 10.1002/pros.24027 – ident: 2023030804355048000_375.oct13_9.n2213.68 doi: doi:10.1093/oxfordjournals.aje.a116237 – ident: 2023030804355048000_375.oct13_9.n2213.74 doi: 10.1093/aje/kwh307 – ident: 2023030804355048000_375.oct13_9.n2213.9 doi: 10.3390/nu11122974 – ident: 2023030804355048000_375.oct13_9.n2213.52 doi: 10.1016/j.ijcard.2012.09.076 – ident: 2023030804355048000_375.oct13_9.n2213.88 doi: 10.1038/sj.ejcn.1602408 – ident: 2023030804355048000_375.oct13_9.n2213.19 doi: 10.1097/00001648-200007000-00013 – ident: 2023030804355048000_375.oct13_9.n2213.38 doi: 10.1161/JAHA.115.002543 – ident: 2023030804355048000_375.oct13_9.n2213.12 doi: 10.1186/1476-511X-13-196 – ident: 2023030804355048000_375.oct13_9.n2213.76 doi: 10.1093/ije/30.5.1119 – ident: 2023030804355048000_375.oct13_9.n2213.11 doi: 10.1080/10408398.2013.828678 – ident: 2023030804355048000_375.oct13_9.n2213.2 doi: 10.1016/j.phrs.2016.09.040 – ident: 2023030804355048000_375.oct13_9.n2213.59 doi: 10.1186/s13643-018-0915-2 – ident: 2023030804355048000_375.oct13_9.n2213.80 doi: 10.1093/ajcn/77.2.319 – ident: 2023030804355048000_375.oct13_9.n2213.91 doi: 10.1186/s12916-016-0730-3 – ident: 2023030804355048000_375.oct13_9.n2213.61 doi: 10.1016/j.cct.2015.09.002 – ident: 2023030804355048000_375.oct13_9.n2213.47 doi: 10.1001/jamacardio.2016.2259 – ident: 2023030804355048000_375.oct13_9.n2213.50 doi: 10.1016/j.nut.2019.110610 – ident: 2023030804355048000_375.oct13_9.n2213.15 doi: 10.1371/journal.pone.0059408 – ident: 2023030804355048000_375.oct13_9.n2213.30 doi: 10.1093/oxfordjournals.aje.a009047 – ident: 2023030804355048000_375.oct13_9.n2213.45 doi: 10.1158/1055-9965.EPI-12-1196-T – ident: 2023030804355048000_375.oct13_9.n2213.57 doi: 10.1093/jn/134.4.919 – ident: 2023030804355048000_375.oct13_9.n2213.33 doi: 10.1093/oxfordjournals.aje.a009710 – ident: 2023030804355048000_375.oct13_9.n2213.93 doi: 10.1016/S0002-8223(02)90346-9 – ident: 2023030804355048000_375.oct13_9.n2213.51 doi: 10.1016/j.jacc.2020.08.073 – ident: 2023030804355048000_375.oct13_9.n2213.85 doi: 10.1002/14651858.CD003177.pub3 – volume: 11 start-page: 24 year: 2005 ident: 2023030804355048000_375.oct13_9.n2213.13 article-title: Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence publication-title: Altern Ther Health Med – ident: 2023030804355048000_375.oct13_9.n2213.42 doi: 10.1017/S000711451400138X – ident: 2023030804355048000_375.oct13_9.n2213.90 doi: 10.1097/MCO.0000000000000439 – ident: 2023030804355048000_375.oct13_9.n2213.20 doi: 10.1017/S0007114514001925 – ident: 2023030804355048000_375.oct13_9.n2213.24 doi: 10.1177/2047487313517576 – ident: 2023030804355048000_375.oct13_9.n2213.84 doi: 10.3181/0711-MR-311 – ident: 2023030804355048000_375.oct13_9.n2213.6 doi: 10.1177/1534735416656052 |
| SSID | ssj0002378965 |
| Score | 2.6620867 |
| SecondaryResourceType | review_article |
| Snippet | AbstractObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes,... To examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular... ObjectiveTo examine the associations between dietary intake and tissue biomarkers of alpha linolenic acid (ALA) and risk of mortality from all causes,... |
| SourceID | pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | n2213 |
| SubjectTerms | alpha-Linolenic Acid - blood alpha-Linolenic Acid - metabolism Bias Biomarkers Blood levels Cancer Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - metabolism Cardiovascular Diseases - mortality Chronic illnesses Cohort analysis Confidence intervals Coronary artery disease Dietary intake Eating - physiology Estimates Fatty acids Heart diseases Humans Linolenic acid Meta-analysis Mortality Neoplasms - metabolism Neoplasms - mortality Protective Factors Reviews Risk Assessment Statistical analysis Systematic review Variables |
| Title | Dietary intake and biomarkers of alpha linolenic acid and risk of all cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort studies |
| URI | https://bmj.com/content/375/bmj.n2213.full https://www.ncbi.nlm.nih.gov/pubmed/34645650 https://www.proquest.com/docview/2593890978 https://www.proquest.com/docview/2582108661 https://pubmed.ncbi.nlm.nih.gov/PMC8513503 |
| Volume | 375 |
| WOSCitedRecordID | wos000708090000004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1756-1833 dateEnd: 20250928 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: M7P dateStart: 19940108 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-1833 dateEnd: 20250928 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: 7X7 dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1756-1833 dateEnd: 20250928 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: 7RV dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-1833 dateEnd: 20250928 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: BENPR dateStart: 19940108 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1756-1833 dateEnd: 20250928 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: M2O dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1756-1833 dateEnd: 20250928 omitProxy: false ssIdentifier: ssj0002378965 issn: 1756-1833 databaseCode: M2P dateStart: 19940108 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RFiEuvB-BsjKIA4embewktrkgHq24dFlVgPa2cmxHBLpJSbJI_DF-Hx7Hu9uFigsX5-FPshWP4xnP5xmA55QZprgzcpJc5HGamDKWzgiLqeEsU7nKEl74ZBN8PBbTqZyEDbcu0CqX_0T_ozaNxj3yA6emu7UVTx28Ov8eY9Yo9K6GFBpbsINREpin7k1WeyyUcSHzLAQUSlh-UMy_7teU-mQG7n5zMfpLw_yTKHlh5Tm--b99vgU3gs5JXg9Cchuu2PoOXDsJXvW78OtdZXvV_iRV3atvlqjaEDyWj8ydtiNNSfyJXOI0UvTiV5ooXRkPQ2b6ADgjWi06u-cuFxmuex6mUbZaMve6vtP7X5J1BGkynJ7xONN0Nm4H2q4lc9erWIWoKdgKZvNte9IN3Md78On46OPb93HI5xAXGeN9rBLr5riWiU55ycsy41QUwt2UmgktD7WUhrEktc4G4kZl2ukXyqRaqNQkWZmw-7BdN7V9CESwojDO2JNM6zQzUlDtBMvgpy6KXNoIRm54Z2E-djNv6rB8hi_9-EfwYjnyMx2ioWNSjrPLoM9W0PMhBMhloN2lCKxbXY9_BE9X1W7-olNG1bZZIEZQzHaVJxE8GKRt1QpDt7NToSPgG3K4AmBs8M2auvriY4Q7RZplh-zRv7v1GK5T5OggQ4ftwnbfLuwTuKp_9FXXjmCLn37Gcsp9KUaw8-ZoPDl1Tyf0gy8nIz_lfgNKXDV3 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VgigXvgsLpRgEEoeG1nYSJ0gIIUrVqu0KoYJ6WxzbEYFutiRZUP8UR34fM052twsVtx44bbR5iqNkZjwvfp4BeCKklVohyeFxEgcht3mQIgkLhFUy0rGOuMp8swnV7yeHh-m7Bfg52QtDsspJTPSB2o4MfSNfxzQd51badfDq-FtAXaNodXXSQqM1i1138gMpW_1yZxPf71Mhtt4evNkOuq4CQRZJ1QSaO7Q0k3ITqlzleaREkiV4kBuZmHTDpKmVkocOM3FldWRwltM2NIkOLY9yLvG6F-AixnFOEjL1_uP0m46QKknjqCtgxGW8ng2_PC-F8M0T8Hh-8vsro_1TmHlqptu69r89o-twtcup2evWCW7AgitvwuX9TjVwC35tFq7R1QkrykZ_dUyXllHZAVImVTUb5czvOGaYcZNKoTBMm8J6GCnvW8ARM3pcuzX8Oa3gXfMwQ75TsaHnMshrXrBZhWzW7g7yODuqXVC1smTHhnhXge6qwtAo1K24aljdajtvw4dzeWrLsFiOSncXWCKzzCKZTaUxYWTTRBh0HEuvNsvi1PVgFc1p0MWbeuCpnIwH9Ke3tx48m1jawHTV3qnpyNFZ0MdT6HFb4uQs0MrE5GajzuytB4-mpzE-0aKTLt1oTJhEUDevmPfgTmvd01EkLasjReiBmrP7KYBqn8-fKYvPvgY6EgUZbch7_76th7C0fbC_N9jb6e_ehyuC9EikRpIrsNhUY_cALpnvTVFXq96RGXw6b6_4DSgujKQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VgioufH8slGIQSBwatrGTOEFCCLGsqAqrPYDUW-rYjprSzZYkC-of48CvY8bJ7nah4tYDp0TJUxwlM_aM_fwG4BkXRiiJSY4fxZEX-Cb3EkzCPG6kCFWkQl9mrtiEHI3i_f1kvAa_5nthiFY57xNdR22mmubI-xim49hKuw76eUeLGA-Gb06-eVRBilZa5-U0WhPZs6c_MH2rX-8O8F8_53z4_vO7D15XYcDLQiEbT_kWrU4nvg5kLvM8lDzOYjzJtYh1sqOTxAjhBxajcmlUqHHEUybQsQqMH-a-wOdegsuSRMsdbXC8mN_hQsZJFHZiRr6I-tnk6GXJuSukgOerA-Ff0e2fJM0zo97w-v_8vW7AtS7WZm9b57gJa7a8BRufOjbBbfg5KGyjqlNWlI36apkqDSM5AmIsVTWb5sztRGYYiRN7odBM6cI4GDHyW8Ax02pW2208nGX2bjuYJp-q2MTlOJjvvGJL5WzW7hpyODOtrVe1dGXLJvhWnurUYqgVqmJcNaxuOZ934MuFfLW7sF5OS3sfWCyyzGCSmwitg9AkMdfoUIZ-c5ZFie3BFppW2vVDdepSPBGldNHZXg9ezK0u1Z0KPBUjOT4P-nQBPWmlT84Dbc7Nb9nq0vZ68GRxG_stWoxSpZ3OCBNzqvIV-T2411r6ohVBy-2YOvRArvjAAkCa6Kt3yuLQaaNjAiHCHfHg36_1GDbQGdKPu6O9h3CVE00JwxEebcJ6U83sI7iivzdFXW05n2ZwcNFO8RsC45VK |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dietary+intake+and+biomarkers+of+alpha+linolenic+acid+and+risk+of+all+cause%2C+cardiovascular%2C+and+cancer+mortality%3A+systematic+review+and+dose-response+meta-analysis+of+cohort+studies&rft.jtitle=BMJ.+British+medical+journal+%28Clinical+research+ed.%29&rft.au=Naghshi%2C+Sina&rft.au=Aune%2C+Dagfinn&rft.au=Beyene%2C+Joseph&rft.au=Mobarak%2C+Sara&rft.date=2021-10-13&rft.pub=BMJ+Publishing+Group+Ltd&rft.issn=0959-8138&rft.eissn=1756-1833&rft.volume=375&rft_id=info:doi/10.1136%2Fbmj.n2213&rft_id=info%3Apmid%2F34645650&rft.externalDocID=PMC8513503 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-1833&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-1833&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-1833&client=summon |